Microglia are the tissue macrophages of the central nervous system (CNS) and the first to respond to CNS dysfunction and disease. Gene expression profiling of microglia during development, under homeostatic conditions, and in the diseased CNS provided insight in microglia functions and changes thereof. Single-cell sequencing studies further contributed to our understanding of microglia heterogeneity in relation to age, sex, and CNS disease. Recently, single nucleus gene expression profiling was performed on (frozen) CNS tissue. Transcriptomic profiling of CNS tissues by (single) nucleus
microglia can adopt a range of phenotypes, depending on the local neural microenvironment and stimulation type (De Biase et al., 2017; Gosselin et al., 2017) . Over the last decade, gene expression profiling of purified microglia has greatly contributed to our understanding and characterization of these cells, both under normal and disease conditions. An overview of these studies will be provided in this review, which will conclude with a detailed description of recent technological developments on nuclear sequencing of microglia.
| Mouse and human microglia transcriptomes by bulk population sequencing
The gene expression profile of mouse and human microglia was first identified using bulk population samples, for example, a large number of purified microglia in one sample. For mouse microglia, the first core microglia signature was generated in 2012 using microarrays in the Immunological Genome (ImmGen) project (Gautier et al., 2012) . Based on this study, Chiu et al. compared microglia microarray data with data from 22 other myeloid cell types collected by the ImmGen project. Ninety-nine genes were identified that were fivefold or more enriched in microglia relative to other myeloid immune cells (Chiu et al., 2013) . Furthermore, they also compared spinal cord microglia RNA-seq data with RNA-seq data obtained from astroglia, motor neurons, and whole spinal cord, yielding 288 genes enriched in microglia.
The overlap between two data sets identified 29 highly specific markers for microglia, including Olfm3, Tmem119, and Siglech (Chiu et al., 2013) .
By direct RNA sequencing of sorted microglia and whole brain samples, Hickman et al. identified a cluster of genes responsible for mouse microglia sensing functions, referred to as the microglia sensome. Comparison with peritoneal macrophages identified 626 differentially expressed transcripts and the top 25 most highly expressed microglia transcripts include the sensome genes: P2ry12, P2ry13, Tmem119, Gpr34, Siglech, Trem2, and Cx3cr1 (Hickman et al., 2013) . These microglia signatures were confirmed in two studies that addressed the transcriptomic and epigenetic differences between mouse microglia and other tissue-resident macrophages (Gosselin et al., 2014; Lavin et al., 2014) . By gene profiling and quantitative mass spectrometry analysis, Butovsky et al. identified 1,572 genes and 455 proteins enriched in mouse microglia compared to CD11b + Ly6C + spleenderived monocytes (Butovsky et al., 2014) . Based on these two datasets, a Nanostring chip was designed to further investigate the differences between microglia and F4/80 + CD11b + macrophages derived from peripheral organs. Two hundred thirty nine genes were specifically expressed by microglia and when compared to other CNS cells (astrocytes, oligodendrocytes, and neurons), 106 genes were microglia specific. P2ry12, Fcrls, Tmem119, Olfml3, Hexb, and Tgfbr1 were identified as unique microglial genes; PU.1 as a microglia-specific transcription factor; and three microglia-specific microRNAs (miR-125b-5p, miR-342-3p , and miR-99a; Butovsky et al., 2014) . Importantly, newborn microglia (P1), cultured primary microglia (P1-2), microglia cell lines (N9, BV2), and embryonic stem cell-derived microglia did not express these microglia signature genes (Butovsky et al., 2014) .
Using microglia marker Tmem119, a mouse microglia gene expression profile during development and after an LPS challenge was generated (Bennett et al., 2016) . During development, 37 of 100 top microglia-enriched genes are consistently upregulated from E17 to P60. Again, a homeostatic microglia core signature was identified, and LPS induced a typical inflammatory gene profile.
All these studies led to the identification of a homeostatic microglia core gene expression signature, which includes Sall1, Hexb, Fcrls, Gpr43, Cx3cr1, Tmem119, Trem2, P2ry12, Mertk, Pros1, and Siglech, genes that are abundantly expressed in microglia compared to other brain or myeloid cells.
In two studies published in 2017 (Galatro,Holtman, et al., 2017; Gosselin et al., 2017) , the human microglia transcriptome was reported. Gosselin et al. expression profiled microglia isolated from surgically resected brain tissue of epilepsy, brain tumor, or acute ischemia patients. Microglia were isolated by Percoll gradient centrifugation and fluorescence-activated cell sorting (FACS) on live-CD11b + CD45 Low CD64 + CX3CR1 High cells, while excluding most activated cells with moderate to high levels of CD45. The 30 most abundant transcripts in microglia across different patients are related to known microglia properties and functions like ramification and motility (P2RY12 and CX3CR1), synaptic remodeling (C3 and C1QA-C), and immune response (HLA-DRA and HLA-B) (Gosselin et al., 2017) .
Comparison of the microglia transcriptome to the transcriptome of cortical brain tissue used to isolate microglia, 881 microglia-enriched (10-fold increased) genes were detected (Gosselin et al., 2017) .
In the study by Galatro et al., microglia were isolated from postmortem CNS tissues from donors without apparent neuropathological abnormalities. Microglia were isolated by mechanical dissociation, Percoll gradient centrifugation, and sorted as live-CD11b high CD45 int cells. Compared to corresponding cortical tissue, 1,297 human microglial signature genes were detected (logFC >3 enrichment). Gene ontology (GO) analysis showed many significantly enriched terms and genes associated with the biological functions of microglia, such as immune signaling and modulation (CD74, CSFR1, C1QA-C), pathogen and self-recognition (MyD88, CLECL1, CIITA), and cell adhesion and motility (ITGAM, CX3CR1, ICAM-1). Also, human microglia expressed many SIGLECs (CD33, SIGLEC5/7-12/14), showing its important role for maintenance of CNS homeostasis (Galatro, Holtman, et al., 2017) .
In both studies, the human and mouse microglia transcriptomes were compared. Gosselin et al. showed that human and mouse microglia are very similar, 13,253 of 15,768 orthologous genes pairs expressed within a fourfold range. At a cutoff of 10-fold difference, they identified 400 human microglia enriched orthologous genes and 293 mouse microglia-enriched orthologous genes. Human microglia are characterized by a higher expression of regulators of the complement system (C2, C3, VSIG4, SERPING1) and genes involved in brain structure development (SYNDIG1, GLDN, CTTNBP2, and ROBO3).
Genes more highly expressed in mouse microglia included Hexb, Sparc, and Sall3 (Gosselin et al., 2017) .
In the study of Galatro et al., the human microglia transcriptome was also compared with mouse microglia transcriptomes (Grabert et al., 2016; Matcovitch-Natan et al., 2016) . An extensive overlap with human microglial data were observed, however, noteworthy differences were also observed. Human microglia-specific genes were shown to involve in immune pathways, example genes are GNLY, CD58, APOBEC3C, CLECL1, CD89, and CARD8 (Galatro, Holtman, et al., 2017) . Most notably, when comparing age-associated changes in microglia gene expression between humans and mice (Grabert et al., 2016) , a suprisingly low overlap was detected. Most genes with an aging-associated change in expression in humans were associated with the actin cytoskeleton (Galatro, Holtman, et al., 2017) . Details on isolation methods, tissues used and which kind of comparison were used to identify microglia signature genes in these studies are summarized in Table 1 .
| Mouse and human microglia heterogeneity revealed by bulk population sequencing
Microglia are plastic cells and their morphology, phenotype, and immune response display region-dependent heterogeneity (Lawson, Perry, Dri, & Gordon, 1990; Yang et al., 2013) . A detailed study of the basal ganglia region revealed region-specific phenotypes of mouse microglia and this microglial diversity was partly determined by the local microenvironment (De Biase et al., 2017) . At the transcriptional level, Grabert et al. was the first to demonstrate transcriptional differences between mouse microglia from the cerebral cortex, hippocampus, cerebellum, and striatum. Cerebellar and hippocampal microglia exhibited a more immune-vigilant state, with higher expression of the genes Camp and H2-Ab1 (Grabert et al., 2016) . Using a microgliaspecific translating ribosome affinity purification approach, it was determined that cerebellar mouse microglia displayed a more pronounced cell clearance phenotype (Ayata et al., 2018) . In contrast, using bulk population RNA-seq, Li et al. detected very limited transcriptomic heterogeneity between Tmem119 + FACS sorted microglia isolated from the above mentioned brain regions (Li et al., 2019 ).
Besides regional differences, gender-dependent heterogeneity in microglia gene expression was also reported. Transcriptomic profiles were generated of microglia from male and female mouse hippocampus and cortex. Male mouse microglia displayed a higher capacity to present antigens and increased responsiveness to purinergic stimuli (Guneykaya et al., 2018) . Expression profiling of microglia isolated from male and female mice revealed that the gene expression program in male microglia was delayed (Hanamsagar et al., 2017) .
Microglia maturation during development is shaped by microbiome-derived short chain fatty acids (Erny et al., 2015) and the effect of the microbiome on mouse microglia differentiation is sexually dimorphic (Thion et al., 2018) . Perturbation of the microbiome had more profound effects in male embryos and female adults. These studies show that the microbiome is important for microglia development and maturation.
Regional heterogeneity was also demonstrated in the human CNS. Human microglia were isolated from grey matter (GM; occipital cortex) and white matter (WM; corpus callosum) from postmortem control and multiple sclerosis (MS) donor CNS. Between WM and GM microglia, 453 differentially expressed genes (logFC >2) were detected in samples from control donors, and 124 genes in MS donor-derived samples. Genes highly expressed in control GM microglia were related to "cytokine-mediated signaling," such as TNFRSF25 and CCL2; WM microglia were enriched for genes involved in "chemotaxis" and "inflammatory response" (CXCR4, ACKR1, GPNMB, NUPR1; van der Poel et al., 2019).
1.3 | Single-cell RNA-sequencing (scRNA-seq) of mouse and human microglia Expression profiling of bulk population human microglia revealed changes associated with age, neurodegenerative diseases and psychiatric disorders (Galatro, Holtman, et al., 2017; Gosselin et al., 2017) , and regional and gender-dependent mouse microglia heterogeneity (Ayata et al., 2018; Grabert et al., 2016; Guneykaya et al., 2018) .
However, expression profiling of populations of cells in bulk precludes
the identification and characterization of microglia subpopulations that (might) exist in the homeostatic brain or that evolve during CNS aging or disease.
ScRNA-seq studies revealed spatio-temporal diversity of mouse and human microglia gene expression during development and in an amyloid mouse model for Alzheimer's disease (AD). Multiple microglia subpopulations were identified that may contribute to, or at least change during, development and/or disease progression (Hammond et al., 2019; Keren-Shaul et al., 2017; Masuda et al., 2019; Matcovitch-Natan et al., 2016; Mathys et al., 2017) .
The first disease-associated single-cell mouse microglia study was published by Keren-Shaul et al. (Keren-Shaul et al., 2017) . In 5XFAD mice, an amyloid AD mouse model, a cluster of disease-associated microglia (DAM) was identified, characterized by the upregulation of genes such as Apoe, Trem2, and Tyrobp. These genes are associated with lipid metabolism and phagocytosis and were already previously identified in a meta-analysis of microglia gene expression changes in relation to aging and CNS disease . These disease-associated microglia subtypes might be promising targets for treatment of neurological diseases (Deczkowska et al., 2018) . In these DAMs, genes associated with homeostatic microglia, such as P2ry12 and Tmem119, were downregulated. While the scRNA-seq study was performed in a mouse model for AD, the expression of some DAM signature genes was confirmed by immunostaining in human AD brain tissue, where these DAMs spatially associated with sites of AD pathology (Keren-Shaul et al., 2017) .
Hammond et al., analyzed microglia states during development, aging and injury in mice (Hammond et al., 2019) . A number of distinct subpopulations of microglia were detected that peak in number during early development, expand during aging and emerge after injury. During mouse aging, small populations of interferon-responive microglia 
| Databases for transcriptome information
There are several online databases that can be used to obtain information on quantitative expression analysis in microglia. The most recent applications are: GOAD , Brain RNA-Seq (Zhang et al., 2014) , and Neuroexpresso (Mancarci et al., 2017) .
The aim of the GOAD database was to generate a platform for glia transcriptomics. Information from the most important glia transcriptome studies was aligned, quantified, and stored in a database.
Brain RNA-Seq (www.brainrnaseq.org; Zhang et al., 2014) provides open access to a comprehensive mouse and human CNS cell types transcriptome data set. The interface of the web application is easy to use. In addition, it is possible to access quantitative expression datasets that are publicly available on the website. Neuroexpresso (neuroexpresso.org; (Mancarci et al., 2017) is a database that combines data generated using GPL339 and GPL1261 micro-array chips together with a single cell RNA-Seq dataset (Tasic et al., 2016) . Only 
| Nuclear and whole-cell transcriptomes
Some studies confirmed a high concordance between nuclear and whole-cell transcriptomes in neurons (Bakken et al., 2018; Lake et al., 2017 Microglia were isolated from adult mouse brain using the protocol as described before . Briefly, the brains were isolated and triturated using a tissue homogenizer. The homogenized brain samples were passed through a 70 μM cell strainer to obtain a single cell suspension. The cells were centrifuged at 220 rcf for 10 min at 4 C and the pellet was resuspended in 24% Percoll gra- Post-mortem human brain tissue of the superior frontal gyrus of two donors was obtained from the Dutch Brain Bank. Microglia were FACS sorted as DAPI neg DRAG5 pos CD45 pos CD11B pos , as previously described (Galatro, Holtman, et al., 2017) . For bulk sequencing, three mice were used per condition and sequenced separately. For single cell/nucleus sequencing, sorted microglia cells/nuclei from three mice/condition were pooled and loaded on a 10× Genomics Chromium chip according to the manufacturer's instructions.
| Nuclei isolation from sorted microglia
The nuclei isolation protocol was adopted from (Krishnaswami et al., 2016 
| Library preparation
For bulk sequencing, total RNA was isolated from either sorted microglia or nuclei using the RNeasy Plus Micro Kit (Qiagen,74034).
RNA quantity and quality were analyzed using an Experion electro- 3 | RESULTS
| Comparison of nuclear and whole-cell transcriptome by bulk sequencing
To evaluate whether nuclear microglia transcriptomes resemble cellular transcriptomes, we performed bulk RNA sequencing on sorted microglia and nuclei isolated from these microglia. Additionally, we included an LPS stimulus to determine whether an acute microglial response is conserved at the nuclear level. Microglia were isolated from mice, 3 hr after an ip injection with PBS or LPS; and from half of these microglia, nuclei were isolated. Sorted microglia and nuclei were expression profiled, with three biological replicates per group (cells/nuclei and PBS/LPS; Figure 1a ). We detected 10,651 uniquely expressed genes in the PBS-cells samples, 10,315
in the LPS-cells samples, 10,225 in the PBS-nuclei samples (88.3% overlap with PBS-cells), and 9,336 in the LPS-nuclei samples (82.8% overlap with LPS-cells). Principal component analysis on these genes indicated segregation of the samples into four distinct groups, associated with PBS/LPS treatment (PC1) and cells/nuclei (PC2; Figure 1b ), respectively. Differential gene expression analysis between the LPS and PBS samples showed that cells and nuclei had a highly similar transcriptional response to a peripheral LPS stimulus (158 DE genes in cells, 232 DE genes in nuclei; Table S1 ).
Among these genes, in response to LPS, 111 genes were upregulated and 47 genes downregulated in cells, and 153 genes upregulated and 79 genes downregulated in nuclei ( Figure 1c and Table S1 ). Importantly, when comparing the logFC values of the genes significantly differentially expressed in the LPS cells versus PBS cells, most of these genes had similar logFC values in the nuclei PBS-LPS comparison, for example, Cxcl10, Tnf, and Il1b, indicating cells and nuclei respond very similarly to LPS (Figure 1d ).
However, 23 genes in the nuclei comparison had a logFC value <1, indicated by cyan dots in Figure 1d . Transcriptional changes in these genes in response to LPS are less pronounced in nuclei. We performed GO analysis to determine the functional properties associated with LPS responsive genes in cells and nuclei (Table S2 ).
Only the top eight most significant terms are depicted, as these were most representative for the overall outcome. As expected, many significantly enriched terms were associated with the inflammatory response of microglia, and showed extensive overlap between cells and nuclei (Figure 1e ).
To determine the similarity between cellular and nuclear microglia expression profiles, we performed differential gene expression analysis between cells and nuclei in both the PBS and LPS condition. Only 22 genes were differentially expressed between cells and nuclei after either PBS (12 DE genes) or LPS treatment (16 DE genes; Figure 1f ). Seven of these differentially expressed genes (mt-Nd4, mt-Cytb, mt-Nd1, mt-Rnr2, mt-Nd2, mt-Rnr1, Rplp2) were mitochondrial-or ribosomal-related and less abundant in nuclei. Five genes were differentially expressed between cells and nuclei, irrespective of treatment (Tmsb4x, Meg3, Ndufa3, Lrp1, Slc50a1). Five genes were differentially expressed between cells and nuclei after an LPS stimulus (P2ry12, Ighm, Arhgef6, Hnrnpab, Yipf3) and five genes were differentially expressed between the PBS samples but not after an LPS stimulus (Wtap, Cxcl10, Nfkbia, Ier2, Usp7). A detailed gene list is provided in Table S3 .
In summary, these data indicate that mouse microglia nuclear transcriptomes are a close approximation of cellular transcriptomes when analyzed using bulk sequencing and that the transcriptional response to LPS observed in nuclei and microglia was highly similar. PBS-nuclei: 480; LPS-cells: 1481; LPS-nuclei: 470). Consistent with previous findings, our nuclear data showed a higher proportion of reads mapping to intronic regions and a lower percentage of mitochondrial genes ( Figure S1a and S1b) (Bakken et al., 2018; Lake et al., 2017) . In addition, a lower percentage of ribosomal genes was detected in the nuclei ( Figure S1c ). PCA analysis of the transcriptomes of individual cells and nuclei showed an extensive overlap, indicating that cellular and nuclear transcriptomes are quite similar ( Figure S2a ).
To identify microglia subpopulations, the cells and nuclei data were combined for dimensionality reduction through UMAP and five clusters were identified using clustering analysis (Figure 2a ). Since quality is an important variable that can have impact on clustering analysis, UMI count and unique gene count per cell were investigated and no clustering based on these parameters was observed ( Figure S2b and   2c ). Clusters 0 and 2 primarily consisted of PBS cells and nuclei and Clusters 1, 3, and 4 mainly contained cells and nuclei isolated from LPS-treated mice (Figure 2b) . Also, a large overlap between cells and nuclei was observed both after PBS and LPS stimulation (Figure 2b) .
Upon LPS stimulation, microglia shift from a homeostatic to an activated state resulting in an activated microglia subpopulation (Sousa et al., 2018) . To confirm the induction of a subset of activated microglia, we determined the expression of homeostatic and activated microglia marker genes reported previously (Keren-Shaul et al., 2017; Sousa et al., 2018) . C1qa expression was detected in all cells and nuclei. Clusters 0 and 2 expressed high levels of homeostatic microglia marker genes such as P2ry12, Cx3cr1, and Mef2c. Clusters 1, 3, and 4 contained activated microglia with an increased expression of Nfkbia, Gpr84, and Cxcl10 (Figure 2d ). Distribution of clusters across different groups showed that the PBS cells and nuclei primarily consisted of Clusters 0 and 2 type microglia/nuclei; upon LPS stimulation, Clusters 1, 3, and 4 were increased in both LPS cells and nuclei, reflecting microglia activation (Figure 2c ). These observations corroborated our bulk sequencing data, showing single microglia nucleus and cellular transcriptomes were highly similar, as well as the detected gene expression changes induced by LPS. In order to determine whether the LPS response was conserved in nuclei, LPS-induced changes in gene expression in cells and nuclei were compared (Figure 2e) . When comparing the logFC values of LPS nuclei versus PBS nuclei with LPS cells versus PBS cells, the majority of the genes responded similarly to LPS in cells and nuclei, for example, Ccl12, Cxcl10, and Ler2 (Figure 2e) . However, 15 genes had an average absolute logFC value <0.25 in LPS versus PBS nuclei (cyan dots in Figure 2e ), indicating that LPS-induced changes in the expression of these genes was less pronounced in nuclei. A detailed gene list of the PBS/LPS comparisons in cells and nuclei is provided in Table S4 . Next, we performed differential gene expression analysis between cells and nuclei from PBS and LPS mice in the single cell/nucleus dataset. In the PBS samples, seven genes were enriched in cells compared to nuclei (logFC >1.5, FDR < 0.05), and except for Tmsb4x, these genes were all mitochondrial-related (mt-Atp6, mt-Cytb, mt-Co3, mt-Nd1, mt-Nd4, mt-Co2) (Table S5 ). In the LPS samples, apart from the previous seven genes, five additional cell-enriched genes were detected (mt-Co1, Rps23, Rps14, Fth1, Rpl32; Table S5 ). Nucleus-enriched genes were only detected in the PBS condition (Acaca, Spag5, and Gm17660) and with a less stringent cut off (logFC <−1 and FDR < 0.05), six genes were enriched in LPS nuclei (Acaca, Kazn, Gm17660, Gm26916, Mylip, and Vps13a) (Table S5) Table S5 ), in agreement with earlier findings (Bahar Halpern et al., 2015; Bakken et al., 2018) . Some representative genes, mentioned above, are depicted in Figure 2f ,g. Taken together, single-microglia nucleus gene expression profiles are a reliable proxy for single microglia transcriptomes in mice.
| Comparison of nuclear and whole cell transcriptome by single cell/nucleus sequencing in human microglia
To investigate whether a similar overlap between the cellular and nuclear transcriptomes was present in human microglia, we isolated microglia and microglia nuclei from fresh post-mortem brain tissue of two human donors. In addition, we froze adjacent tissue blocks of the same donors and then isolated nuclei from these samples to evaluate whether nuclei isolated from frozen tissue can be used to determine microglia transcriptomes. After removal of doublets and low-quality cells and nuclei, 2,620 cells, 3,836 fresh nuclei, 275 frozen microglia nuclei were obtained from Donor 1 and 2,653 cells, 2046 fresh nuclei, and 405 frozen microglia nuclei from Donor 2. Frozen microglia nuclei were obtained by exclusion of non-microglia nuclei (like astrocytes) from the NeuN neg OLIG2 neg nuclei population. We observed a similar pattern in the distribution of mapping stats as we found in mouse,
where intronic reads were more abundant in the nuclear samples and lower percentage of mitochondrial and ribosomal genes were detected in nuclei samples ( Figure S1 ). PCA analysis of the transcriptomes of microglia cells and nuclei indicated that cells and nuclei overlap and that the variation in the dataset is mainly explained by the difference between the donors (Figure 3a ). After dimensionality reduction and clustering, five microglia subclusters were identified ( Figure 3b ). Like in the mouse data, clustering was not affected by the quality of the cells/nuclei ( Figure S3a and 3b ). Clear donor variation was observed in the UMAP visualization, where Clusters 0 and 1 were mainly derived from Donor 2, and Clusters 2, 3, and 4 were primarily derived from Donor 1 (Figure 3b,c) . The microglia gene C1QA was more abundant in microglia from Donor 1, where homeostatic gene P2RY12 was more abundantly expressed in microglia from Donor 2. CD74 was more homogeneously expressed across microglia from Donors 1 and 2 (Figure 3d ). The distribution of different clusters across different groups showed that, similar to the mouse data, freshly isolated nuclei from human microglia cells are a good proxy for the human single cell microglia transcriptome (Figure 3e ). Importantly, microglia nuclei isolated from frozen CNS tissue contained all the subpopulations identified in the fresh nuclei/microglia samples from the same donors but with a small shift in cluster ratios (Figure 3e ). Nuclear and cellular transcriptomes were generated from the same FACS-sorted microglia sample, allowing for a direct comparison between the fresh cells and nuclei, within each donor. However, for the frozen nuclei, although from the same donors, nuclei were isolated from adjacent tissue using a different isolation method, tissue homogenization, and sucrose density centrifugation. The modest difference in cluster composition in the frozen nuclei might be caused by differences in the isolation protocols for fresh and frozen nuclei, and that slightly different areas of brain tissue were used for the fresh and frozen nuclei (Table S6) .
Overall, microglia nuclear transcriptomes from both fresh and frozen CNS tissue are a good proxy for freshly isolated microglia and potential subpopulations present in the tissue.
| DISCUSSION
Single nucleus RNA sequencing is considered to have several advantages over single cell RNA sequencing. First, nuclei are more resistant to mechanical stress and cryopreservation, which would make large collections of well-characterized (frozen) tissues in biorepositories amenable for single nucleus profiling (Krishnaswami et al., 2016) . Second, single-nucleus RNA sequencing is less cell type-biased than single cell RNA sequencing. Some cell (sub)types are more vulnerable to tissue dissociation than other cell types, resulting in potential underand over-representation of cell types or subsets thereof in the data (Bakken et al., 2018) . Several studies using brain tissue have shown that nuclei reflect transcriptional changes at the tissue level, single cell level and also recapitulate subtypes and diversity in neurons (Habib et al., 2016; Lake et al., 2016; Lake et al., 2017) . However, for microglia, it is yet unknown whether nuclei can serve as an alternative for cellular transcriptomes, whether nuclear transcriptomes contain enough information to identify microglia subtypes, and whether this is amenable to frozen CNS tissues. Hence, we performed a systematic comparison of mouse and human fresh microglia and nuclei, and additionally microglia nuclei isolated from frozen human brain tissue.
The number of microglia in the brain is relatively low (Keller, Ero, & Markram, 2018) and, as a consequence the number of microglia in total CNS tissue single cell sequencing data is also relatively low (Darmanis et al., 2015; Mathys et al., 2019) . In order to enrich for microglia nuclei from frozen tissue, nuclei from neurons and oligoden- Figure S2d ) and human ( Figure S3c ) microglia nuclei.
To investigate the differences and similarities between single cell and single nucleus RNA sequencing (Selewa et al., 2019) , we compared these technologies in LPS-challenged mice, as that induces a strong and well characterized transcriptional response in microglia (Holtman, Raj, et al., 2015) . First, we used bulk RNA sequencing to determine to what extent the nuclear and cellular gene expression profiles in mice overlap. As expected, we obtained less RNA from nuclei, approximately 20% of the amount of total RNA typically isolated from microglia (data not shown). Only 22 genes were differentially expressed between mouse cells and nuclei, indicating a highly similar expression profile (Figure 1f) (Li et al., 2019) , we decided to include an LPS challenge.
Three hours after an ip LPS injection, a subset of microglia had shifted from a homeostatic (Clusters 0 and 2) to an activated state (Clusters 1, 3, and 4) (Figure 2c,d) , which was different from the transcriptional shift observed in microglia 24 hr after an LPS challenge where all cells lost their homeostatic signature and were activated (Sousa et al., 2018) . Importantly, the cluster distribution of the cells and nuclei in both treatment groups was very similar, indicating that the heterogeneity observed in the cells and nuclei is rather similar, also during activation. Direct comparison of the LPS response in cells and nuclei (both using bulk and single-cell data), indicated that most of the LPSinduced transcriptional changes in microglia were also detected in nuclei (Figures 1d and 2e ).
Next, we investigated whether human microglia nuclei, including nuclei isolated from frozen CNS tissues, could reliably recapitulate cellular transcriptomes generated with microglia isolated from fresh CNS tissue. Clustering analysis of cells and nuclei from both donors combined showed that cells and fresh nuclei clustered very similarly.
The distribution of clusters in frozen nuclei was slightly altered but all the clusters detected in fresh microglia were recapitulated in frozen nuclei (Figure 3e ). The fresh nuclei were isolated from the same microglia sample used for cellular profiling, and hence should be extremely similar. The frozen nuclei were isolated from an adjacent tissue block of the same donor which may had a slightly different cellular composition. Differences in the relative amounts of WM and GM between the fresh and frozen tissue samples would already result in changes in gene expression and cluster sizes. In addition, the isolation methods used for fresh and frozen nuclei were different, possibly contributing to the observed differences by preferential enrichment or loss of nuclear subtypes (Cluster 2 in Donor-1 and Cluster 1 in Donor-2), due to different sensitivities to freeze-thaw attrition. Importantly, donor variation, a reported parameter in single-cell microglia data (Olah et al., 2018) , was equally detected in microglia cells and both fresh and frozen nuclei in the two donors analyzed. This indicates that donor-associated changes in gene expression were preserved in frozen microglia nuclei and that they hence reliably recapitulate the gene expression profile of fresh tissue microglia (Figure 3e ).
By comparing nuclear and whole cell microglia transcriptomes by bulk sequencing and single nucleus/cell sequencing in human and mouse, we confirm that microglia nuclei are a reliable proxy for the single cell microglia transcriptome. This enables the use of banked human specimens to investigate microglia in neurodegenerative disease and neurological disorders.
| FUTURE PERSPECTIVES
Gene expression profiling of isolated cells, either in bulk or at the single cell levels, is inherently associated with loss of spatial, contextual information of the used tissue. Relatively recently, two technologies were reported where gene expression profiles were generated while retaining spatial information of the analyzed tissue section.
The first technology, spatial transcriptomics (Stahl et al., 2016) , makes use of glass slides on which oligo d(T) primers with positional barcodes are spotted to capture the mRNA present in overlaid tissues. These positional barcodes enable the maintenance of positional information throughout the process of cDNA synthesis, library preparation, and sequencing. With decreasing spot diameters and spot distance, resolution will further increase, which is required for single cell analysis. A second approach to sequencing RNAs in the context of cells and tissues is fluorescent in situ sequencing (FISSEQ) (Lee et al., 2014) . FISSEQ is a technology combining RNA-FISH and next generation sequencing, allowing for detection of multiple RNAs at subcellular resolution. Where FISSEQ provides a higher resolution than spatial transcriptomics, it requires a panel of oligonucleotides to detect mRNAs of interest where spatial transcriptomics is unbiased and does not required a priori knowledge about genes of interest.
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